Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript.
| Image |  |
|---|---|
| Description | scientific article published on 27 August 2009 |
| Author/s |
author: Claire M Lucas Athina Giannoudis |
| Publication date | August 27, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |